Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNS-3379 for Upper Extremity Motor Function in Ischemic Stroke
NCT03254160Phase 2Terminated
- Sponsor
- Dart NeuroScience LLC
- Start
- Nov 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of DNS-3379 in ischemic stroke, sponsored by Dart NeuroScience LLC. Started Nov 2017; status: terminated.
02
Drugs
DNS-3379
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03254160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03254160.